Author

Matthew Dysthe

ORCID: 0000-0002-6559-3498
Observed ORCID: 0000-0002-6559-3498
OpenAlex ID: A5087018713
2020 · Matthew Dysthe, Robin Parihar · Advances in experimental medicine and biology · 221
2019 · Manbir Sandhu, Anja M. Touma, et al. · Proceedings of the National Academy of Sciences · 101
2021 · Amanda Rosewell Shaw, Caroline E. Porter, et al. · Communications Biology · 47
2021 · Keehun Kim, Shayla Paulekas, et al. · Proceedings of the National Academy of Sciences · 26
2017 · Rabia U. Malik, Matthew Dysthe, et al. · Scientific Reports · 26
2025 · Ishwar Navin, Matthew Dysthe, et al. · Cancer Immunology Research · 13
2025 · Matthew Dysthe, Ishwar Navin, et al. · Journal for ImmunoTherapy of Cancer · 13
2022 · Ishwar Navin, Matthew Dysthe, et al. · Journal for ImmunoTherapy of Cancer · 6
2022 · Matthew Dysthe, Ishwar Navin, et al. · Journal for ImmunoTherapy of Cancer · 1
2022 · Rebecca Brock, Alesandra Echeandia-Marrero, et al. · Journal for ImmunoTherapy of Cancer
2018 · Manbir Sandhu, Matthew Dysthe, et al. · The FASEB Journal
2017 · Matthew Dysthe, Rabia U Malik, et al. · The FASEB Journal
Works count: 19
Citation count: 480
H-index: 8
I10-index: 8
Year
Topic
Type